INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
DM

Dobek Maria

Vice President, AccountingCIK 0002032671

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells0 / 2
Max Insider Score40
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
DM
Dobek MariaVice President, Accounting
JANXJanux Therapeutics, Inc.
Open-market sale
SELL$29K
2,038 sh
May 11, 2026May 13, 2026
traded May 11, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Janux Therapeutics, Inc.Vice President, Accounting · Jan 2, 2026
21
DM
Dobek MariaVice President, Accounting
JANXJanux Therapeutics, Inc.
Grant or award
A
—
18.9K sh
Jan 2, 2026
Jan 2, 2026
traded Jan 2, 2026
+0d
SEC FORM 4

Evidence

9
DM
Dobek MariaVice President, Accounting
JANXJanux Therapeutics, Inc.
Grant or award
A—
42.6K sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC FORM 4

Evidence

40
DM
Dobek MariaVice President, Accounting
JANXJanux Therapeutics, Inc.
Open-market sale
SELL$20K
1,462 sh
Jan 2, 2026Jan 2, 2026
traded Jan 2, 2026
+0dSEC FORM 4

Evidence